The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Repositioning Drugs for PD, 2011Repositioning BCG Vaccination as an Immunostimulant for Slowing the Progression of PD
Objective/Rationale:
We recently demonstrated that strong immune system stimulation created by treating pre-clinical models with a safe vaccine (called BCG) can have a restorative effect on... -
Clinical Intervention Awards, 2011NH004 Films for Sialorrhea in PD Patients (2011)
Objective/Rationale:
Uncontrolled saliva or drooling (sialorrhea) is a socially debilitating condition with high prevalence in Parkinson’s disease (PD) patients. The NH004 treatment to control... -
LRRK2, 2011Neuropathological tissue collection in LRRK2 Mutant carriers with and without PD
Objective/Rationale:
Neuropathological studies have been vital in Parkinson’s disease (PD) research. The gold-standard diagnosis of PD is confirmed at autopsy. In addition, information on key proteins... -
MJFF Research Grant, 2011Generation of LRRK2 Lentiviral Vectors
Objective/Rationale:
Overexpression of LRRK2 in mammalian cells, either transient or as stable cell lines, has proven cumbersome and quite inefficient. This can be partly attributed to the large size... -
Research Grant, 2011LRRK2 Effects on Neural Differentiation (Supplement 1)
Promising Outcomes of Original Grant:
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) account for up to 13% of familial Parkinson's disease (PD) patients. One widely held... -
Rapid Response Innovation Awards, 2011Assessing the Therapeutic Potential of iDA Neuronal Cells in Autologous Strategy
Objective/Rationale:
We have shown recently that three transcription factors can promote the conversion of skin fibroblasts into induced dopaminergic neuronal (iDAN) cells with remarkable functional...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.